In one series, 123I-FP-CIT SPECT discriminated pathologically proven DLB from AD with 88% sensitivity and 100% specificity as the latter is not associated with loss of striatal DAT binding [113, 114]. Here, SLC6A3 is linked to Alzheimer disease.